Complete Summary and Solutions for Biotechnology and Its Applications – NCERT Class XII Biology, Chapter 10 – Agricultural Biotechnology, Medical Biotechnology, Transgenic Animals, Ethical Issues

Comprehensive summary and explanation of Chapter 10 'Biotechnology and Its Applications' from the NCERT Class XII Biology textbook, covering biotechnological applications in agriculture including genetically modified crops, tissue culture, biopesticides, medical biotechnology for producing human insulin, gene therapy, molecular diagnosis, transgenic animals and related ethical considerations, with detailed answers to all textbook exercises.

Updated: 1 week ago

Categories: NCERT, Class XII, Biology, Chapter 10, Biotechnology, Agriculture, Medicine, GM Crops, Transgenic Animals, Gene Therapy, Ethics, Summary, Questions, Answers
Tags: Biotechnology, Applications, GM Crops, Transgenic Animals, Gene Therapy, Tissue Culture, Molecular Diagnosis, Biopesticides, Ethical Issues, Human Insulin, NCERT, Class 12, Biology, Chapter 10, Summary, Questions, Answers
Post Thumbnail
Biotechnology and Its Applications - Class 12 NCERT Chapter 10 - Ultimate Study Guide, Notes, Questions, Quiz 2025

Biotechnology and Its Applications

Chapter 10: Biology - Ultimate Study Guide | NCERT Class 12 Notes, Questions, Examples & Quiz 2025

Full Chapter Summary & Detailed Notes - Biotechnology and Its Applications Class 12 NCERT

Overview & Key Concepts

  • Chapter Goal: Explore biotechnological tools for improving agriculture, medicine, and industry; focus on GMOs, recombinant therapeutics, gene therapy, transgenic animals, and ethical concerns. Exam Focus: Principles (e.g., Bt toxin mechanism, RNAi process), applications (e.g., golden rice, insulin production), diagrams (e.g., pro-insulin maturation, dsRNA protection). 2025 Updates: Emphasis on sustainable biotech (e.g., climate-resilient crops), CRISPR ethics ties. Fun Fact: Bt cotton reduced pesticide use by 50% in India. Core Idea: Biotech harnesses living systems for human benefit while addressing biosafety. Real-World: mRNA vaccines (COVID) build on gene therapy concepts. Ties: Links to Ch 11 (tools) and Ch 12 (principles). Expanded: All subtopics (10.1-10.4) covered point-wise with principles, steps, biotech relevance, pros/cons for visual/conceptual learning.
  • Wider Scope: From plant tissue culture to ethical biopiracy; role in food security, healthcare equity, and biodiversity conservation.
  • Expanded Content: Detailed mechanisms (e.g., Bt protoxin activation), case studies (e.g., Basmati patent), global impacts.
Fig. 10.1: Cotton boll (Description)

Labelled diagram: (a) Destroyed boll with bollworms visible; (b) Fully mature undamaged boll. Visual: Side-by-side comparison showing pest damage vs. healthy GM crop.

10.1 Biotechnological Applications in Agriculture

  • Options for Food Production Increase: (i) Agro-chemical based (fertilizers/pesticides - expensive, environmental harm); (ii) Organic (sustainable but low yield); (iii) Genetically engineered crops (precise, efficient).
  • Green Revolution Limitations: Tripled supply but insufficient for population; relies on agrochemicals unaffordable for developing farmers; conventional breeding too slow.
  • Tissue Culture & Totipotency: Regenerate whole plants from explants (any cell/part) in sterile nutrient media (sucrose, salts, vitamins, auxins/cytokinins). Discovered 1950s; enables rapid propagation.
  • Micropropagation: Produces thousands of genetically identical somaclones (e.g., tomato, banana, apple) commercially; visit lab for hands-on.
  • Virus-Free Plants: Meristem (apical/axillary) virus-free; culture to obtain healthy plants (e.g., banana, sugarcane, potato).
  • Protoplast Fusion & Somatic Hybridization: Fuse naked protoplasts (wall-digested cells) from desirable varieties; grow into hybrids (e.g., pomato - tomato + potato, but not commercially viable due to undesired traits).
  • Genetically Modified Organisms (GMOs): Genes altered for traits; benefits: (i) Abiotic stress tolerance (cold/drought/salt/heat); (ii) Pest resistance (reduced pesticides); (iii) Lower post-harvest losses; (iv) Efficient mineral use (soil conservation); (v) Enhanced nutrition (e.g., golden rice - Vitamin A enriched).
  • Additional GMO Uses: Tailor-made plants for starches, biofuels, pharmaceuticals.
  • Pest-Resistant Plants: Bt Toxin: From Bacillus thuringiensis (Bt); cry genes cloned into plants (e.g., Bt cotton - cryIAc for bollworms; Bt corn - cryIAb for borers). Mechanism: Protoxin crystals inactive in bacteria; insect gut alkaline pH activates, binds midgut cells, forms pores, causes lysis/death. Insect-specific, safe for non-targets.
  • Nematode Resistance: RNAi: Silences mRNA via dsRNA (cellular defense against viruses/transposons). Strategy: Introduce nematode genes via Agrobacterium into host; produces sense/antisense RNA → dsRNA → mRNA degradation; parasite cannot survive (e.g., tobacco vs. Meloidogyne incognita).
Fig. 10.2: Host plant-generated dsRNA triggers protection against nematode infestation (Description)

(a) Roots of control plant heavily infested; (b) Transgenic roots protected 5 days post-infection. Visual: Side-by-side root images showing galls in control vs. clean transgenic roots.

10.2 Biotechnological Applications in Medicine

  • Recombinant Therapeutics Impact: Mass production of safe drugs; no immune responses (unlike animal-derived); 30 approved globally, 12 in India.
  • 10.2.1 Genetically Engineered Insulin: For adult-onset diabetes; animal insulin causes allergies. Human insulin: Two chains (A/B) linked by disulfides; synthesized as pro-insulin (with C-peptide, removed for maturation). Production: Eli Lilly (1983) - Separate A/B DNA in E. coli plasmids; extract, combine via disulfides. Cannot be oral (digested by proteases).
  • Diagram: Pro-Insulin Maturation: Pro-insulin → remove C-peptide → insulin (A + B chains).
  • 10.2.2 Gene Therapy: Corrects defective genes by inserting normal ones (e.g., via retroviral vectors). First case (1990): 4-year-old with ADA deficiency (immune disorder from gene deletion). Steps: Culture patient's lymphocytes, insert ADA cDNA, reinfuse (periodic, not permanent); embryonic insertion for cure. Bone marrow transplant/enzyme replacement alternatives but not fully curative.
  • 10.2.3 Molecular Diagnosis: Early detection vital; conventional methods (serum/urine) too late. Techniques: rDNA, PCR (amplifies low pathogen DNA/RNA, e.g., HIV mutations, genetic disorders); probes (radioactive ssDNA/RNA hybridize to target, autoradiography detects mutations); ELISA (antigen-antibody interaction for pathogen/antibody detection).
Fig. 10.3: Maturation of pro-insulin into insulin (simplified) (Description)

Pro-insulin structure: A and B chains linked by disulfides, with C-peptide loop; arrow shows cleavage to mature insulin (A + B) + free C-peptide.

10.3 Transgenic Animals

  • Definition: Animals with foreign genes inserted/expressed (e.g., mice 95%, rats, rabbits, pigs, sheep, cows, fish).
  • Reasons for Creation:
    • (i) Normal Physiology/Development: Study gene regulation/effects (e.g., insulin-like growth factor via introduced genes).
    • (ii) Disease Study: Models for human diseases (e.g., cancer, cystic fibrosis, rheumatoid arthritis, Alzheimer’s) to test treatments.
    • (iii) Biological Products: Produce medicines (e.g., Rosie cow milk with human alpha-lactalbumin - 2.4g/L, better for babies; α-1-antitrypsin for emphysema; attempts for PKU/cystic fibrosis).
    • (iv) Vaccine Safety: Test vaccines (e.g., transgenic mice for polio safety, potential monkey replacement).
    • (v) Chemical Safety Testing: Toxicity in sensitive models (faster results than non-transgenic).

10.4 Ethical Issues

  • Regulation Need: Manipulations require ethical standards to evaluate harm/help to organisms/ecosystems; unpredictable GM effects on environment.
  • GEAC Role: Genetic Engineering Approval Committee assesses GM research validity/safety for public release.
  • Patent Problems: Grants for GM uses create issues; public anger over companies patenting indigenous resources (e.g., 1997 US patent on Basmati rice-derived variety, restricting Indian sales; attempts on turmeric/neem).
  • Biopiracy: Unauthorized use of bio-resources/traditional knowledge by MNCs without compensation; industrialized nations exploit developing countries' biodiversity/knowledge. Solutions: Laws for benefit-sharing (e.g., Indian Patents Bill amendment for emergencies/R&D).

Summary

  • Biotech yields useful products via microbes/plants/animals; tissue culture/somatic hybridization for plant varieties; rDNA for GMOs with novel traits (yield/stress tolerance/nutrition/pest resistance).
  • Medicine: Safe therapeutics (insulin), gene therapy (ADA), diagnosis (PCR/ELISA); transgenic animals for models/products/testing.
  • Ethics: GEAC oversight, anti-biopiracy laws essential.

Why This Guide Stands Out

Point-wise depth, diagrams described, real cases (Bt India impact); free 2025 with mnemonics, ethics debates for retention.

Key Themes & Tips

  • Aspects: Catalyst optimization, downstream processing, biosafety vs. innovation.
  • Tip: Memorize cry genes, RNAi steps; draw mechanisms for diagrams.

Exam Case Studies

Bt cotton yield boost; ADA therapy ethics.

Project & Group Ideas

  • Model pomato fusion demo.
  • Debate: GMOs vs. organic farming.
  • Research: Golden rice in malnutrition.